Connect with us

Health

COVID-19: Seven have died in UK after receiving AstraZeneca vaccine, says regulator

Published

on

The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.

The British acknowledgement of deaths comes as several European countries have paused the use of the AstraZeneca jab over a potential link to blood clots.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) said in a statement that “Out of the 30 reports up to and including 24 March, sadly 7 have died.”

The reports of thrombosis, submitted by medics or members of the public via a government website, came after 18.1 million doses of the vaccine had been administered in the country.

Most of the cases (22) were a rare clotting condition called cerebral venous sinus thrombosis. Eight cases saw people suffer other types of thrombosis combined with low levels of blood platelets, which help blood clot.

There were no reports of blood clots from the Pfizer-BioNTech vaccine, the UK regulator said, adding that “our thorough review into these reports is ongoing”.

But MHRA chief executive Dr June Raine stressed that the benefits far outweighed any risks. “The public should continue to get their vaccine when invited to do so,” she said.

Europe update expected

Both the MHRA and European Medicines Agency (EMA) say no causal link has yet been established between the blood clotting case and the AstraZeneca vaccine.

But growing concerns have prompted a number of countries to pause rollout of the vaccine or limit it to older people due to the relatively young age of those who suffered blood clots.

Netherlands on Friday halted vaccinations with the AstraZeneca jab for people under the age of 60 after five new cases among younger women, one of whom died.

Germany has suspended the use of the vaccine for those under 60 after 31 cases of blood clots, most of them among younger and middle-aged women.

A number of other countries including France have imposed a similar age restrictions, while Denmark and Norway have suspended all use of the vaccine.

The European Medicines Agency (EMA), which like the World Health Organization previously declared the AstraZeneca vaccine safe, is expected to announce updated advice on the issue on April 7.

It said Wednesday that there had been 62 cases worldwide of cerebral venous sinus thrombosis, 44 of them in the European Economic Area, which includes the European Union, Iceland, Liechtenstein and Norway.

This figure did not include all Germany’s cases, however.

More than 9.2 million AstraZeneca jabs have been administered in the region.

The EMA said it believes the vaccine is safe and that experts have found no specific risk factors such as age, gender or medical history.

‘Weight of evidence’

Paul Hunter, a medical microbiologist at Britain’s University of East Anglia, told AFP that he had initially thought the link between vaccination and blood clots was likely to be a “random association”.

As evidence mounts of clusters in separate countries, “the weight of evidence is now looking towards Oxford-AstraZeneca actually being the cause of these adverse events”, he said.

Nevertheless, the risk for the unvaccinated of dying from Covid is “substantially greater,” he said.

A spokeswoman for AstraZeneca told AFP that patient safety is its “highest priority”.

UK, EU and World Health Organization regulatory bodies have concluded that the benefits “significantly outweigh the risks across all adult age groups”, she said.

AstraZeneca said last month following US efficiency trials that its vaccine is 76 percent effective at preventing the disease. It also said data for the EU and the UK showed no increased risk of blood clots.

The UK has administered more than 31 million first vaccine doses, using both the Oxford-AstraZeneca and the Pfizer-BioNTech jabs. People cannot choose which one they get.

The UK in June 2020 ordered 100 million doses of the Oxford-AstraZeneca vaccine and supported its development. It also ordered 30 million doses of the Pfizer-BioNTech vaccine the same year.

 

AFP

Comments

Health

Ebola: WHO seeks 5,000 health workers for DR Congo

Published

on

Health workers in Personal Protective Equipment (PPE) practice safety check protocols on each other during a training by medical charity, Médecins Sans Frontières (MSF) to reinforce regional emergency response capacity for Ebola in the Democratic Republic of Congo (DRC) at Ongata Rongai, Kajiado County in Kenya on July 10, 2026.

The World Health Organisation (WHO) on Tuesday said it needed an additional 5,000 health workers to help contain the Ebola outbreak spreading across the Democratic Republic of Congo.

The outbreak, officially detected on May 15, has spread to six provinces in the country’s conflict-affected eastern and northeastern regions.

The WHO, citing official Congolese figures, said more than 6,600 people had been confirmed infected, while 3,175 had died since the outbreak began.

The development has put further pressure on health facilities in the affected areas, many of which are already struggling with shortages of medical personnel and other essential resources.

Ebola is a highly contagious viral disease transmitted through contact with the bodily fluids of infected persons. It can cause severe bleeding, organ failure and death.

The UN health agency said it was working to establish 3,000 beds in Ebola treatment centres across the affected areas to cope with the rising number of patients.

A senior technical official with the WHO, Luca Fontana, said the expansion would require thousands of additional healthcare workers.

“More than 900 beds have been built within the first two months of the response, and we have now reached close to 1,400 beds across 59 treatment centres,” Fontana told a press briefing in Geneva.

He said another 1,600 beds would be required to meet the rapidly increasing demand.

“Despite this extraordinary effort, we estimate that another 1,600 beds will be required to meet the rapidly growing needs,” he said.

Fontana said nearly 4,000 healthcare workers were currently working in the treatment centres, adding that 5,000 more were urgently needed.

He said the Congolese Ministry of Health was racing against time to identify qualified medical personnel from other parts of the country for deployment to the affected provinces.

“The problem is to identify those fast enough to make sure that we can cover the growing need,” Fontana said.

He stressed that fully staffed treatment centres would be critical to saving lives and bringing the outbreak under control.

“Every treatment centre that is fully staffed and functional means more life saved and a stronger chance of bringing this outbreak under control,” he said.

The current outbreak is caused by the Bundibugyo strain of Ebola, for which there is currently no approved vaccine or treatment. Several vaccines and treatments, however, are being tested.

The outbreak has also been complicated by the security situation in the affected regions, where government presence is weak, healthcare infrastructure is limited and armed groups have operated for decades.

Fontana said the geographical spread of patients seeking treatment was another indication that the outbreak was expanding.

He explained that while most patients initially admitted to treatment centres came from Bunia, the capital of Ituri Province, infected people were now arriving from villages “far beyond” the original epicentre.

He described the development as “a clear sign” that the outbreak was spreading and said the WHO response would have to adapt accordingly.

Ebola has killed more than 15,000 people in Africa over the past 50 years.

The previous major Ebola outbreak in the Democratic Republic of Congo, which lasted from 2018 to 2020, killed nearly 2,300 people out of about 3,500 reported infections.

Continue Reading

Health

Trump cleared for office, doctor orders weight loss ahead of 80th birthday

Published

on

By

United States President Donald Trump has been declared medically fit to continue in office, with his physician describing him as being in “excellent health” while recommending weight loss and increased physical activity weeks before his 80th birthday.

The White House disclosed on Friday that Trump underwent his annual medical and dental examination on Tuesday at Walter Reed Military Hospital near Washington, amid growing scrutiny over his health and fitness for office.

In a three-page medical memo released by the White House, Trump’s physician, US Navy Captain Sean Barbabella, said the president demonstrated strong overall physical and mental capacity.

“President Trump remains in excellent health, demonstrating strong cardiac, pulmonary, neurological, and overall physical function,” Barbabella stated, adding that the president was “fully fit to carry out all duties of the Commander-in-Chief and Head of State.”

However, the physician advised Trump to adopt healthier lifestyle measures, including dietary adjustments, increased physical activity, continued weight loss and low-dose aspirin therapy for cardiovascular prevention.

According to the report, Trump, who will turn 80 on June 14, stands at 6ft 3in tall and weighs 238 pounds (108 kilograms), about 14 pounds more than he weighed during his last full annual medical check-up in April last year.

Despite concerns surrounding his age, the report noted that Trump’s cardiac health reflected an estimated age roughly 14 years younger than his chronological age.

The president also reportedly scored a perfect “30 out of 30” in a cognitive assessment, a result Trump has repeatedly cited in public while contrasting himself with his Democratic predecessor, former President Joe Biden.

The medical report further addressed concerns over bruising frequently seen on Trump’s right hand, attributing it to “minor soft tissue irritation” caused by repeated handshaking and aspirin use.

The memo also referenced scarring on Trump’s right ear linked to the assassination attempt against him during a campaign rally in Butler, Pennsylvania, in 2024, when a gunman opened fire, killing a supporter and slightly wounding the president.

Trump’s latest health evaluation comes amid public concerns after he was occasionally seen appearing drowsy during White House meetings and events. He had also previously been diagnosed with chronic venous insufficiency, a condition that affects blood circulation in the veins and can lead to swelling in the legs.

Reacting shortly after Tuesday’s examination, Trump wrote on his Truth Social platform that the medical exercise had gone “PERFECTLY,” while the White House later shared his photograph online with the caption, “PERFECT BILL OF HEALTH!”

The release of the report also sparked debate in the United States after the White House initially delayed making the medical details public, breaking with the traditional practice of releasing presidential health summaries shortly after such examinations.

Trump has long faced criticism over transparency regarding his health records, with questions also raised over the scheduling and description of his medical evaluations since returning to office.

Continue Reading

Health

Oyo confirms Lassa fever death in Ibadan, activates emergency response, traces contacts

Published

on

The Oyo State Government has confirmed a Lassa fever case at the University College Hospital, Ibadan, where a 44-year-old woman died, prompting the activation of emergency response measures and immediate contact tracing to contain the disease.

The state Commissioner for Health, Oluwaserimi Ajetunmobi, disclosed this in a statement on Wednesday, saying, “The patient died on April 11, 2026, while receiving treatment, while laboratory confirmation of Lassa fever was received on April 13.”

She added that the Ministry of Health had swiftly activated its emergency response system, including the establishment of an Incident Management System to coordinate response activities across the state.

According to her, “All identified contacts of the deceased are being closely monitored, while necessary measures have been taken to ensure a safe and dignified burial in line with public health protocols.”

Ajetunmobi urged residents to seek immediate medical attention if they experience symptoms such as persistent fever, weakness, sore throat, vomiting, diarrhoea, unexplained bleeding, chest pain or difficulty breathing.

She stressed, “Early presentation at health facilities significantly improves the chances of survival.”

The commissioner explained that Lassa fever is a viral haemorrhagic disease transmitted primarily through contact with food or household items contaminated by urine or faeces of infected rodents.

“It can also spread from person to person through contact with bodily fluids, especially in healthcare settings where infection prevention measures are not strictly observed,” she said.

She advised residents to maintain strict environmental hygiene, including proper waste disposal, safe storage of food in rodent-proof containers and avoiding drying food items on bare ground or roadsides.

Ajetunmobi also urged households to seal holes and entry points to prevent rodent access, while emphasising regular handwashing and good personal hygiene.

Residents, she said, should report suspected cases through designated emergency lines, while health workers must strictly adhere to infection prevention and control protocols.

Reaffirming the government’s commitment, the commissioner said surveillance had been intensified across the state, with all health facilities placed on alert.

“There is no cause for panic. The situation is under control, and Lassa fever is both preventable and treatable when detected early,” she assured.

Continue Reading

Trending

All Rights Reserved. Copyright © 2026 MegaIcon Magazine